Understanding Colitis Research
Ulcerative colitis is a chronic inflammatory disease of the colon and rectum. This article explains why mesenchymal stem cells are being studied and what shapes a treatment decision.
- Autoimmune
- 2 min
08/18/2026
About Ulcerative Colitis
Ulcerative colitis is a long-lasting inflammatory condition of the colon and rectum. Common symptoms include abdominal pain, diarrhea, urgency and flares, the periods when inflammation becomes more active. Because severity differs so much between people, careful evaluation and ongoing medical care are essential.
Many people manage ulcerative colitis with medication prescribed by a gastroenterologist, and some go through long periods with few symptoms.
The Focus of Current Studies
Inflammatory bowel disease is a developing area of regenerative medicine research. For ulcerative colitis, studies center on whether particular cell therapies could help control inflammation and support the repair of damaged tissue in the lining of the gut.
Why Mesenchymal Stem Cells
Mesenchymal stem cells have attracted attention for two properties: their ability to influence the immune system, known as immunomodulation, and their part in tissue repair. Researchers are still working out how these cells interact with immune cells in the intestine and whether they might help create conditions that favor healing.
These questions are still being studied, and results vary between patients.
Factors in a Treatment Decision
Anyone interested in a regenerative option should first have a thorough medical examination. Several factors shape the decision:
- medical history
- how severe and how extensive the disease is
- current medications
- previous treatments and how well they worked
Talking It Through
At Regeneration Clinic Panama, patients and their families can discuss personalized options once the evaluation is complete, and that evaluation decides whether treatment is appropriate. When it is, we use mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords, produced in our in-house laboratory. Before deciding, every patient should hear about the possible benefits, the limitations and the risks, and results vary between patients.
08/18/2026
Related Articles
Frequently asked questions
Read Full FAQAnswers about safety, cost and what to expect.
Our proprietary stem cell standard, refined over 10 years of research and treatment. Sourced from Wharton’s Jelly and produced entirely in-house.
The most common side effect is temporary pain at the injection site. Headache, nausea or fatigue happen rarely and usually resolve within 24 hours. No long-term side effects have been documented to date.
In the US, FDA approval follows a long, costly path for each specific product and condition, and for most conditions mesenchymal stem cell therapy hasn’t completed that path yet. Research continues worldwide, with hundreds of clinical trials underway. Patients travel to Panama for access they can’t get at home, delivered with in-house production, image-guided precision and a team that tells them honestly what to expect.
We treat neurological, autoimmune, orthopedic and sports, cardiovascular and fertility conditions, autism, and support healthy aging. Our medical team reviews every case individually before recommending a protocol.
Yes. Treatment takes place at our clinic in Panama City. Your consultation and case review happen remotely before you book any travel.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance.

Still have a question?
Ask us directly. A patient advocate will reply personally.






